PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of gutGutVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
Gut. 2001 March; 48(3): 418–424.
PMCID: PMC1760155

FAS engagement drives apoptosis of enterocytes of coeliac patients

Abstract

BACKGROUND—Villus atrophy is the most distinctive sign of untreated coeliac disease (CD) and epithelial apoptosis is considered to be involved in this stage of the coeliac lesion. The extent of villus atrophy is, however, not homogeneous and patients with patchy or mild lesions have been described.
AIMS—To address: (a) the degree of "patchiness" in untreated CD patients; and (b) to clarify if apoptosis, and eventually which trigger drives it, causes epithelial damage.
PATIENTS—Twenty of 40 untreated, 14 treated coeliac patients, and 15 controls received five or more multiple duodenal biopsies; the remaining 20 untreated CD patients had no more than three biopsies.
METHODS—All biopsies were analysed to monitor the presence of a "flat" mucosa. Biopsies of 14 untreated, 10 treated coeliacs, and seven controls were cultured with or without gliadin. DNA fragmentation was studied by terminal deoxynucleotidyl transferase (TdT) mediated dUTP digoxigenin nick end labelling (TUNEL), and FAS and Ki67 expression by immunohistochemistry. Antiendomysium antibodies (EMA) were surveyed in biopsy culture supernatants.
RESULTS—A pattern of patchy duodenal lesions was observed in all untreated CD patients biopsied up to five times. High enterocyte FAS expression, and a high number of TUNEL+ and Ki67+ enterocytes were detected in areas with villus atrophy but not in those with a normal morphology (p<0.001). Conversely, EMA in culture supernatants and signs of immunological activation were present in all untreated CD biopsies. In vitro gliadin challenge increased the number of TUNEL+ and Ki67+ enterocytes (p<0.001 v cultures with medium alone) only in "flat" biopsies. Neutralising anti-FAS monoclonal antibodies were found to control gliadin induced enterocyte apoptosis (p>0.01) while agonist anti-FAS monoclonal antibody increased it (p<0.001).
CONCLUSIONS—Patchy lesions are observed in untreated CD mucosa and epithelial FAS engagement is a key trigger in driving villus atrophy in CD.


Keywords: apoptosis; FAS; enterocytes; coeliac disease

Full Text

The Full Text of this article is available as a PDF (228K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Przemioslo RT, Lundin KE, Sollid LM, Nelufer J, Ciclitira PJ. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut. 1995 Jun;36(6):874–879. [PMC free article] [PubMed]
  • Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology. 1992 Jan;102(1):330–354. [PubMed]
  • Savidge TC, Shmakov AN, Walker-Smith JA, Phillips AD. Epithelial cell proliferation in childhood enteropathies. Gut. 1996 Aug;39(2):185–193. [PMC free article] [PubMed]
  • MacDonald TT. Epithelial proliferation in response to gastrointestinal inflammation. Ann N Y Acad Sci. 1992;664:202–209. [PubMed]
  • Picarelli A, Maiuri L, Mazzilli MC, Coletta S, Ferrante P, Di Giovambattista F, Greco M, Torsoli A, Auricchio S. Gluten-sensitive disease with mild enteropathy. Gastroenterology. 1996 Sep;111(3):608–616. [PubMed]
  • Loft DE, Nwokolo CU, Ciclitira PJ. The diagnosis of gluten sensitivity and coeliac disease--the two are not mutually inclusive. Eur J Gastroenterol Hepatol. 1998 Nov;10(11):911–913. [PubMed]
  • Moss SF, Attia L, Scholes JV, Walters JR, Holt PR. Increased small intestinal apoptosis in coeliac disease. Gut. 1996 Dec;39(6):811–817. [PMC free article] [PubMed]
  • Nagata S, Golstein P. The Fas death factor. Science. 1995 Mar 10;267(5203):1449–1456. [PubMed]
  • Maiuri L, Auricchio S, Coletta S, De Marco G, Picarelli A, Di Tola M, Quaratino S, Londei M. Blockage of T-cell costimulation inhibits T-cell action in celiac disease. Gastroenterology. 1998 Sep;115(3):564–572. [PubMed]
  • Maiuri L, Picarelli A, Boirivant M, Coletta S, Mazzilli MC, De Vincenzi M, Londei M, Auricchio S. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology. 1996 May;110(5):1368–1378. [PubMed]
  • Picarelli A, Maiuri L, Frate A, Greco M, Auricchio S, Londei M. Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease. Lancet. 1996 Oct 19;348(9034):1065–1067. [PubMed]
  • Auricchio S, De Ritis G, De Vincenzi M, Gentile V, Maiuri L, Mancini E, Porta R, Raia V. Amines protect in vitro the celiac small intestine from the damaging activity of gliadin peptides. Gastroenterology. 1990 Dec;99(6):1668–1674. [PubMed]
  • Auricchio S, De Ritis G, De Vincenzi M, Magazzù G, Maiuri L, Mancini E, Minetti M, Sapora O, Silano V. Mannan and oligomers of N-acetylglucosamine protect intestinal mucosa of celiac patients with active disease from in vitro toxicity of gliadin peptides. Gastroenterology. 1990 Oct;99(4):973–978. [PubMed]
  • Alderson MR, Tough TW, Braddy S, Davis-Smith T, Roux E, Schooley K, Miller RE, Lynch DH. Regulation of apoptosis and T cell activation by Fas-specific mAb. Int Immunol. 1994 Nov;6(11):1799–1806. [PubMed]
  • Maiuri L, Rossi M, Raia V, Garipoli V, Hughes LA, Swallow D, Norén O, Sjöström H, Auricchio S. Mosaic regulation of lactase in human adult-type hypolactasia. Gastroenterology. 1994 Jul;107(1):54–60. [PubMed]
  • Maiuri L, Raia V, De Marco G, Coletta S, de Ritis G, Londei M, Auricchio S. DNA fragmentation is a feature of cystic fibrosis epithelial cells: a disease with inappropriate apoptosis? FEBS Lett. 1997 May 19;408(2):225–231. [PubMed]
  • Kuitunen P, Kosnai I, Savilahti E. Morphometric study of the jejunal mucosa in various childhood enteropathies with special reference to intraepithelial lymphocytes. J Pediatr Gastroenterol Nutr. 1982;1(4):525–531. [PubMed]
  • Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 1998 Oct 16;282(5388):490–493. [PubMed]
  • Linsley PS, Wallace PM, Johnson J, Gibson MG, Greene JL, Ledbetter JA, Singh C, Tepper MA. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science. 1992 Aug 7;257(5071):792–795. [PubMed]
  • Vogelsang H, Schwarzenhofer M, Granditsch G, Oberhuber G. In vitro production of endomysial antibodies in cultured duodenal mucosa from patients with celiac disease. Am J Gastroenterol. 1999 Apr;94(4):1057–1061. [PubMed]
  • Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology. 1993 Sep;105(3):910–922. [PubMed]
  • Biagi F, Parnell ND, Ellis HJ, Ciclitira PJ. Endomysial antibody production is not related to histological damage after in vitro gluten challenge. Eur J Gastroenterol Hepatol. 2000 Jan;12(1):57–60. [PubMed]

Figures and Tables

Figure 1  Figure 1
DNA fragmentation and Ki67 expression in coeliac disease (CD) and control intestine. (A) DNA fragmentation in enterocytes of CD and control intestine. (B) Expression of Ki67 in crypt enterocytes of CD and control intestine (mean (SD)). Untreated CD, ...
Figure 2
FAS expression in untreated coeliac disease (CD) duodenum. A marked change in expression of FAS is observed at the border between regions with normal villus architecture (low expression; left side) and those with villus atrophy (very high expression; ...
Figure 3  Figure 3
In vitro organ culture of untreated coeliac disease (CD) intestine with villus atrophy: DNA fragmentation and Ki67 expression after 24 hour challenge with medium or gliadin. Effect of neutralising anti-FAS M3 or agonist anti-FAS CH-11 monoclonal ...
Figure 4
In vitro organ culture of untreated coeliac disease (CD) intestine with normal villus architecture. DNA fragmentation (A) and Ki67 expression (B) (mean (SD)) after 24 hour challenge with medium or gliadin and effect of agonist anti-FAS CH-11 ...
Figure 5
In vitro organ culture of treated coeliac disease (CD) intestine: effect of 24 hour gliadin challenge on enterocyte expression of FAS. (A) FAS expression after 24 hour challenge with medium alone. Faint staining is observed on cell membranes ...

Articles from Gut are provided here courtesy of BMJ Publishing Group